Shabbir Anik, Ph.D. will join Althea Technologies as president and chief executive officer. Dr. Anik will lead the company’s expansion of its product development, clinical trial and commercial manufacturing services.
      
“We are delighted to welcome Dr. Anik to Althea and feel that his background and expertise is a wonderful match for the company,” said Dr. Magda Marquet, co-chair of Althea Technologies. “He is a rare blend of scientist, manager and leader, and we are excited about Althea’s continued success with Shabbir at the helm. . . As we continue to grow to serve our clients, Shabbir’s experience in manufacturing, his understanding of the critical interplay of services in bringing a product to commercial success, and his ability to manage these activities across the globe will be invaluable to Althea.”
      
Dr. Anik previously served as president of Pharmaceutical Development Services (PDS) at Patheon, Inc., where he was responsible for building and managing the company’s global PDS business. He also served as senior director of Pharmaceutical Development and Operations for the biotechnology company Neurex. Dr. Anik began his career at Syntex, serving in positions of increasing responsibility, including serving as vice president and program director.